{"product_id":"uchicago-medicine-21st-annual-international-ultmann-chicago-lymphoma-symposium-2024","title":"UChicago Medicine 21st Annual International Ultmann Chicago Lymphoma Symposium 2024","description":"\u003ch3\u003eUChicago Medicine 21st Annual International Ultmann Chicago Lymphoma Symposium 2024\u003c\/h3\u003e\n\u003cstrong\u003eInclude: 26 videos + 1 pdf, size: 7.52 GB\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e Target Audience: oncologists\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e Information:\u003c\/strong\u003e\n\u003cbr\u003e\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-control-plaintext\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"field field-name-field-course-summary field-type-text-with-summary field-label-hidden\"\u003e\n\u003cdiv class=\"field-items\"\u003e\n\u003cdiv class=\"field-item even\"\u003e\n\u003cdiv\u003eThe 21st International Ultmann Chicago Lymphoma Symposium (IUCLS) is a continuation of an annual conference dedicated solely to the science and clinical care of lymphoma. It has been organized to honor the achievements of Dr. John Ultmann, a pioneer in the treatment of lymphoma, who devoted his life to the understanding of this disease. He was particularly known for his work on the staging of Hodgkin lymphoma and the utility of staging as a guide for treatment.\u003c\/div\u003e\n\u003cdiv\u003eWe are fortunate to have a multitude of the world’s experts in lymphoma speak each year at the conference. The audience is comprised of national practicing oncologists, advanced nurse practitioners and physician assistants, nurses, residents, fellows, and the Chicago academic community that includes five academic centers. This year’s program will be offered live on April 19-20, 2024, and represents the 21st IUCLS.\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cbr\u003e\u003cbr\u003eUChicago Medicine 21st Annual International Ultmann Chicago Lymphoma Symposium 2024\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eThis is a certified continuing medical education (CME) activity that focuses on the biologic, diagnostic, and therapeutic aspects of Hodgkin lymphoma and non-Hodgkin lymphoma. The format of the meeting includes a combination of expert presentations, interactive case discussions, poster and abstract presentations, and an opportunity for question-and-answer debates. Additionally, the entire conference will be certified for nursing continuing education credits.\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eThe goal of this educational activity is to facilitate a forum for physicians, nurses, researchers, and other healthcare professionals to discuss biologic, diagnostic, and therapeutic aspects of Hodgkin and non-Hodgkin lymphoma.\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cbr\u003e\u003cbr\u003eIUCLS will gather both domestic and international clinicians and researchers specializing in the treatment of patients with lymphoma.This event gives opportunities for providers to explore vital information on clinical updates and research in order to ensure they are using the latest treatment options in their practice.\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"group-target-audience field-group-div\"\u003e\n\u003cstrong\u003eTarget Audience\u003c\/strong\u003e\n\u003cbr\u003e\u003cdiv class=\"field field-name-field-target-audience field-type-text-long field-label-hidden\"\u003e\n\u003cdiv class=\"field-items\"\u003e\n\u003cdiv class=\"field-item even\"\u003e\n\u003cdiv\u003eThis activity is designed for practicing oncologists, advanced nurse practitioners, physician assistants, residents, fellows, nurses, pharmacists, and other healthcare professionals interested in the treatment and diagnosis of lymphoma.\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"group-learning-objectives field-group-div\"\u003e\n\u003cstrong\u003eLearning Objectives\u003c\/strong\u003e\n\u003cbr\u003e\u003cdiv class=\"field field-name-field-learning-objectives field-type-text-long field-label-hidden\"\u003e\n\u003cdiv class=\"field-items\"\u003e\n\u003cdiv class=\"field-item even\"\u003e\n\u003cbr\u003e\u003cbr\u003eAt the conclusion of this educational activity, participants will be able to:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003e\n\u003cdiv\u003eEvaluate the latest treatment strategies for patients with indolent and aggressive forms of B-cell non-Hodgkin lymphoma, such as follicular lymphoma, diffuse large B-cell lymphoma, and mantle cell lymphoma;\u003c\/div\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cdiv\u003eAssess the safety and efficacy of current and emerging therapeutic approaches for the care of patients with Hodgkin lymphoma;\u003c\/div\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cdiv\u003eCompare and contrast the various patient and disease-related factors that may impact therapeutic decisions for patients with newly diagnosed and previously treated CLL;\u003c\/div\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cdiv\u003eDiscuss approaches to the care of patients with rare lymphoma subtypes, including Burkitt lymphoma and peripheral T-cell lymphoma;\u003c\/div\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cdiv\u003eDevelop strategies to communicate with and utilize the entire multidisciplinary team during the continuum of care of patients with lymphoma.\u003c\/div\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003e Topics:\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003e2024 IUCLS Agenda FINAL.pdf\u003cbr\u003eAre Checkpoint Inhibitors the Standard of Care for Frontline Hodgkin Lymphoma.mp4\u003cbr\u003eArtificial Intelligence and Computational Oncology.mp4\u003cbr\u003eBispecifics for FL.mp4\u003cbr\u003eBispecifics for LBCL Focus on Management of Toxicities in the Community.mp4\u003cbr\u003eDuel Symposium Measuring MRD is the Standard of Care in CLL No.mp4\u003cbr\u003eDuel Symposium Measuring MRD is the Standard of Care in CLL Yes.mp4\u003cbr\u003eEnsuring the Progress in Hodgkin Lymphoma Applies to All.mp4\u003cbr\u003eEpigenetics in T-cell Lymphoma Has the Promise Been Fulfilled.mp4\u003cbr\u003eHematopathology Tumor Board.mp4\u003cbr\u003eImplementation of Reducing Barriers to Accessing Lymphoma Care.mp4\u003cbr\u003eKeynote Presentation The Evolution and State of Lymphoma Research.mp4\u003cbr\u003eManagement of Advanced CTCL.mp4\u003cbr\u003eNovel Therapeutics for T-cell Lymphoma and Lessons Learned from the Current Regulatory Environment.mp4\u003cbr\u003eOverview of Bispecific Antibodies- Comparing and Contrasting Current and Emerging Agents.mp4\u003cbr\u003ePanel Discussion with Cases Hodgkin’s Lymphoma.mp4\u003cbr\u003ePI3K Is Targeting This Pathway Still Valuable.mp4\u003cbr\u003ePractical Aspects of Bispecifics Supportive Care Strategies.mp4\u003cbr\u003ePrimer on CRISPR and its Impact on Cancer Research and Treatment.mp4\u003cbr\u003eSequencing of Bispecifics with Other Therapies.mp4\u003cbr\u003eSpecial Considerations in Treating Patients with Lymphoma – Impact of Patient Age AYA Patients.mp4\u003cbr\u003eSpecial Considerations in Treating Patients with Lymphoma – Impact of Patient Age Elderly Older Patients.mp4\u003cbr\u003eSupportive Care for Patients with HL Receiving Immunotherapy- Differentiating Checkpoint Inhibitors vs Antibody-Drug Conjugates.mp4\u003cbr\u003eTargeting BTK- Inhibitors vs Degraders.mp4\u003cbr\u003eThe Next Frontier of Targeted Therapy in Lymphoma.mp4\u003cbr\u003eWhat is the Standard of Care in Second Line Hodgkin Lymphoma.mp4\u003cbr\u003eWho Benefits the Most from Radiation in Hodgkin Lymphoma.mp4\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954448797794,"sku":"MED-AMB03770","price":40.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/UChicago-Medicine-21st-Annual-International-Ultmann-Chicago-Lymphoma-Symposium-2024-scaled-1.jpg?v=1779377032","url":"https:\/\/meducourse.com\/products\/uchicago-medicine-21st-annual-international-ultmann-chicago-lymphoma-symposium-2024","provider":"Meducourse","version":"1.0","type":"link"}